相关实验视频

Updated: Jan 7, 2026

Structural Characterization of Mannan Cell Wall Polysaccharides in Plants Using PACE

Structural Characterization of Mannan Cell Wall Polysaccharides in Plants Using PACE

Published on: October 16, 2017

通过乙化设计功能性葡萄甘南以准肠道微生物群的调节

Sheng Ke¹, Anqi Wang¹, Padraig Strappe²

¹College of Food Science and Engineering, Tianjin University of Science and Technology, Tianjin, 300457, China.

Carbohydrate polymers

|December 31, 2025

概括

康雅克葡萄甘 (KGM) 的乙化改变了其结构,降低了粘度和肠道发酵. 乙化KGM (AKGM) 选择性地促进了像Prevotella_9这样的有益细菌,同时抑制了病原体.

科学领域:

生物化学生化学
微生物学微生物学
材料科学材料科学材料科学

背景情况:

康杰克葡萄甘 (KGM) 是一种具有潜在健康益处的多糖化合物.
修改KGM的结构可能会改变其物理化学性质和生物活动.

研究的目的:

为了研究KGM在乙化后的结构和物理化学变化.
评估乙化KGM (AKGM) 对肠道微生物群发酵和SCFA生产的影响.
探索AKGM在针对性肠道健康干预方面的潜力.

主要方法:

乙化KGM的.
用光谱分析 (FTIR,NMR) 来进行结构确认.
风湿学测量粘度和凝强度.
试验室发酵试验用于评估肠道微生物群的变化和SCFA生成.

主要成果:

乙化将乙基引入KGM,由FTIR和NMR证实.
由于分子间相互作用较弱,AKGM的粘度和凝强度下降.
与KGM相比,AKGM显示发酵动力学降低和SCFA产量降低.
AKGM调节了肠道微生物群,降低了Firmicutes/Bacteroidota的比率,并选择性地促进了Prevotella_9.
AKGM显著抑制了诸如Escherichia-Shigella之类的病原体的生长.

结论:

乙化改变了KGM的分子结构,影响了其物理性质和肠道发酵.
AKGM显示出选择性肠道微生物群调节的潜力,促进有益细菌和抑制病原体.
这些发现表明,AKGM可能是个性化肠道健康干预的宝贵工具.

关键词:

乙化乙化是一种康杰克葡萄康曼南 (Konjak Glucomannan) 是一种葡萄糖.微生物群中的微生物群分子结构分子结构.短链脂肪酸短链脂肪酸

更多相关视频

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines

Published on: November 25, 2017

Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota

Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota

Published on: May 23, 2025

相关概念视频

Oligosaccharide Assembly

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...